β-blocker
ႁိၵ်ႈ
[မႄးထတ်း]β-blocker (တူဝ်ၼမ် β-blockers)
- တူဝ်ယေႃႈ ၶွင် beta blocker.
- 2008 ၾႅပ်ႇဝႃႇရီႇ 28, ironjustice, “Beta-Blocker”, in sci.med.cardiology, Usenet[1], retrieved 2022-05-17:
- Carvedilol, an antihypertensive agent, has been in clinical use for several years. In addition to its function as a β-blocker, carvedilol has been shown to act as an antioxidant.
- (ၶႅၼ်းတေႃႈ ၽိူမ်ႉသႂ်ႇပၼ် လွင်ႈပိၼ်ႇၽႃႇသႃႇတႆး တွၼ်ႈတႃႇ လွင်ႈဢၢင်ႈဢိင်ဢၼ်ၼႆႉ)
- 2008, C.J. van Boxtel, B. Santoso, I.R. Edwards, Drug Benefits and Risks: International Textbook of Clinical Pharmacology - Revised 2nd Edition[2], page 325:
- Blockade of β2-adrenoceptors by non-selective β-blockers causes side-effects such as bronchoconstriction, vasoconstriction and hypoglycaemia.
- (ၶႅၼ်းတေႃႈ ၽိူမ်ႉသႂ်ႇပၼ် လွင်ႈပိၼ်ႇၽႃႇသႃႇတႆး တွၼ်ႈတႃႇ လွင်ႈဢၢင်ႈဢိင်ဢၼ်ၼႆႉ)
- 2016, Anne H. Child, Diagnosis and Management of Marfan Syndrome[3], page 51:
- β-blocker inhibits adrenaline β activation release into blood from sympathetic nerves and adrenal gland. In the heart, β-receptor stimulation increases heart rate and cardiac contraction, and excitation conduction in atrioventricular node. Thus β-blocker therapy decreases heart rate, cardiac contraction and myocardial oxygen consumption.
- (ၶႅၼ်းတေႃႈ ၽိူမ်ႉသႂ်ႇပၼ် လွင်ႈပိၼ်ႇၽႃႇသႃႇတႆး တွၼ်ႈတႃႇ လွင်ႈဢၢင်ႈဢိင်ဢၼ်ၼႆႉ)